SYDE2: A Protein Involved in Synaptic Development and Function

Target Name: SYDE2

NCBI ID: G84144

SYDE2

SYDE2: A Protein Involved in Synaptic Development and Function

SYDE2, also known as synapse defective protein 1 homolog 2, is a gene that encodes a protein known to play a crucial role in the development and maintenance of synapses, which are the structural elements that connect neurons in the brain. Synapses are responsible for transmitting electrical and chemical signals between neurons, and their dysfunction has been linked to a wide range of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

SYDE2 is a protein that is expressed in many different tissues and cells throughout the body, including the brain. It is primarily localized to the axon of neurons, where it is involved in the formation and maintenance of the synapse. SYDE2 has been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to adapt and change in response to experience and learning.

One of the key functions of SYDE2 is its role in the formation of synapses. Synapses are formed from a complex of proteins, including SYDE2, which are involved in the formation of the synapse header and the precise position of the synapse relative to the dendrites of the neuron.

SYDE2 is also involved in the maintenance of synapses. Studies have shown that SYDE2 helps to keep the synapse open and maintain the integrity of the synapse, which is important for the efficient transmission of electrical and chemical signals.

In addition to its role in synaptic formation and maintenance, SYDE2 has also been shown to be involved in the regulation of synaptic plasticity. Studies have shown that SYDE2 can alter the levels of a protein called PSD-90, which is involved in synaptic plasticity. Additionally, SYDE2 has been shown to interact with a protein called Calbindin, which is also involved in synaptic plasticity.

SYDE2 is also associated with the development of certain neurological disorders. Studies have shown that individuals with certain genetic mutations, such as those that cause Fragile X syndrome, have lower levels of SYDE2 and are more likely to have impaired synaptic development and function. Additionally, individuals with certain psychiatric disorders, such as depression and anxiety, have been shown to have lower levels of SYDE2 as well.

Given the involvement of SYDE2 in the regulation of synaptic plasticity and the development of certain neurological disorders, it is possible that SYDE2 could be a drug target or biomarker for the development of new treatments for these disorders. For example, drugs that target SYDE2 have been shown to be effective in treating certain neurological disorders, such as Alzheimer's disease and Parkinson's disease. Additionally, studies have shown that individuals with certain genetic mutations, such as those that cause Fragile X syndrome, have lower levels of SYDE2 and are more likely to have impaired synaptic development and function. Therefore, targeting SYDE2 with drugs that promote synaptic development and function could be a promising approach to treating these disorders.

In conclusion, SYDE2 is a protein that is involved in the formation and maintenance of synapses, and has been shown to be involved in the regulation of synaptic plasticity. Its involvement in the development and maintenance of synapses makes it a potential drug target or biomarker for the development of new treatments for certain neurological disorders. Further research is needed to fully understand the role of SYDE2 in synaptic development and function, as well as its potential as a drug target or biomarker.

Protein Name: Synapse Defective Rho GTPase Homolog 2

Functions: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state

The "SYDE2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYDE2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets